United States. Congress. House. Committee on Commerce. (1997). Prescription Drug User Fee Reauthorization and Drug Regulatory Modernization Act of 1997: Report, together with additional views (to accompany H.R. 1411) (including cost estimate of the Congressional Budget Office). U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Commerce. Prescription Drug User Fee Reauthorization and Drug Regulatory Modernization Act of 1997: Report, Together with Additional Views (to Accompany H.R. 1411) (including Cost Estimate of the Congressional Budget Office). [Washington, D.C.?: U.S. G.P.O., 1997.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Commerce. Prescription Drug User Fee Reauthorization and Drug Regulatory Modernization Act of 1997: Report, Together with Additional Views (to Accompany H.R. 1411) (including Cost Estimate of the Congressional Budget Office). U.S. G.P.O., 1997.